Back to Authors

Brunton, Nichole E

0000-0002-1867-6768

Mayo Clinic

Cardiovascular Medicine Fellow, Virginia Commonwealth University, Richmond, VA, USA.

Citations 7

Inferior Vena Cava Filter Placement in Pregnancy and the Postpartum Period: A Single-Center Experience

Seminars in Thrombosis and Hemostasis | February 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2803-3295 | PMID 41638247

Abstract Guidelines recommend placement of inferior vena cava filters (IVCFs) in patients with acute proximal lower extremity deep vein thrombosis (DVT) and a contraindication to anticoagulation. IVCF placement during pregnancy or immediately postpartum presents technical challenges and is not extensively described in the existing literature. This study aimed to describe the use of IVCFs in the obstetric population along with outcomes related to filter placement. Retrospective chart review of all patients at Mayo Clinic from 2001 to 2020 with an IVCF at the time of conception or who underwent placement during pregnancy/postpartum. About 24 pregnancies in 23 women (mean age 26.3 years, range 18–41) were included: 5 (21%) with IVCF placement prior to pregnancy, 7 (29%) during pregnancy, and 12 (50%) during postpartum. IVCFs placed during pregnancy were frequently in the suprarenal position, in 5 (71%) cases. Meanwhile, 16 (94%) were deployed in an infrarenal position prior to pregnancy and postpartum. Complications included multiple attempts to remove the IVCF (n = 2), severe angulation (n = 4), embedded struts (n = 3), fracture (n = 1), and one case of cardiac tamponade (n = 1). Complications were more common when placement was performed prior to pregnancy or during pregnancy (2, 40% and 4, 57% respectively) versus postpartum (2, 17%). IVCF placement prior or during pregnancy/postpartum is uncommon and is associated with a high incidence of complications, although most did not fundamentally impact clinical outcomes. While IVCFs remain an option for clinicians treating pregnant and postpartum patients, these should be considered a last resource.
Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines

Vascular Medicine | December 23, 2024 | Volume: 30 | Issue: 1 | Pages: 110-113

10.1177/1358863x241306354 | PMID 39713878

Subclinical coronary artery disease and perioperative cardiac events in patients undergoing peripheral artery bypass surgery

Vascular Medicine | September 25, 2024 | Volume: 29 | Issue: 6 | Pages: 720-722

10.1177/1358863x241280070 | PMID 39319860

Steering the multidisciplinary landscape of vascular medicine: Collaboration as the key to success for aspiring vascular medicine specialists

Vascular Medicine | August 13, 2024 | Volume: 29 | Issue: 4 | Pages: 462-466

10.1177/1358863x241262723 | PMID 39135266

SVM Communications: International perspectives on vascular medicine and updates from the Intersocietal Accreditation Commission (IAC)

Vascular Medicine | April 7, 2023 | Volume: 28 | Issue: 2 | Pages: 172-174

10.1177/1358863x231160842 | PMID 37025022

SVM Communications: Increasing awareness of vascular medicine as a specialty

Vascular Medicine | February 9, 2023 | Volume: 28 | Issue: 1 | Pages: 97-98

10.1177/1358863x221146588 | PMID 36759933

“No Shoes. No Shirt. No Thrombus.” Could Vitamin D Levels Change the Tune for Patients With Antiphospholipid Syndrome?

The Hematologist | January 17, 2023 | Volume: 20 | Issue: 1 | Pages: No page available

10.1182/hem.v20.1.2023110